Skip to main content
. 2023 May 6;19:15. doi: 10.1186/s13005-023-00362-5

Table 2A.

Cephalometry initial findings with regard to the skelettal sagittal and vertical craniofacial configuration of a study group of 20 patients diagnosed Down Syndrome

Patient Gender Sagittal cranial configuration Vertical cranial configuration Anterior tooth angulation
ΔWITS
(NR: 0 ± 1 mm)
Δ ANB
(NR: 2.0 ± 2°)
Overall Outcome (class) Δ ML-NSL
(NR: 32 ± 2°)
Δ NL-NSL
(NR: 8.5 ± 2°)
Δ ML-NL
(NR: 23 ± 3°)
Δ ArGoMe
(NR:128 ± 7°)
Overall Outcome Δ UP1-NSL
(NR: 102 ± 2°)
Δ LO1-ML
(NR: 90 ± 3°)
1 m 0 -0.8 I -1.7 3.4 -5.1 -7.1 brachyfacial 9.1 4.3
2  m -2.9 -7.7 III -25.4 -7.2 -18.2 -30.8 brachyfacial 26.6 17.9
3 f -6.7 -4.5 III -1.5 2.5 -3.9 -9.3 brachyfacial 21.8 8.5
4 f -8.1 -6.5 III -6.5 -0.5 -6.5 0.1 brachyfacial 10.5 -15.5
5 f -1.8 -3.4 III -7.1 -1.8 -9.8 -7.2 brachyfacial 12.6 6.3
6 m 3.4 6.6 II 9.2 -0.5 9.7 4.9 dolichofacial -1.2 -3.1
7  m -7.2 -0.3 III -2.6 -4.1 1.5 -9.5 brachyfacial 18.6 10.8
8  m -4.4 -5.4 III -7.5 -1.2 -6.3 -15.5 brachyfacial 13.7 -2.7
9  m -3 -3.4 III -3.6 -0.7 -2.9 -0.4 dolichofacial -15.8 -6.5
10  m -4.1 -2.2 III -5.7 -1.8 -3.9 -17 brachyfacial -0.7 -13.9
11  m -6.4 -2.3 III -2.4 -0.8 -1.6 -5.4 brachyfacial 2.6 4.4
12 f -3.2 -0.3 III -8.3 -5.7 -2.6 -16.6 brachyfacial 18.8 15.6
13 m 0.8 2.6 I 1.3 -0.4 -17.6 -9.8 brachyfacial 5.4 2.7
14 f -14.9 -6.3 III -7.4 0.4 -7.8 0 brachyfacial 15 -5
15 m 1.5 2.7 I 8.9 -0.8 9.7 5.2 dolichofacial 1.1 -1.3
16 m 0.2 -1.6 I -0.8 0.6 -1.4 -21.9 brachyfacial -3.6 8.1
17 f -6.2 -7.9 III -10.2 -0.9 -9.3 -14.5 brachyfacial 16.2 5.2
18  m -9.9 -4.1 III 8.3 9.8 -1.6 -5.4 brachyfacial -1.6 -18.9
19  m -4 0.2 III -0.7 -0.3 -0.4 -9.5 brachyfacial -4 10
20  m -1.2 3.2 III -11.2 -1.7 -9.6 -18.4 brachyfacial 17.3 26.1
Mean, SD

-3.91

± 4.33

-2.07

± 3.90

-3.75

± 7.83

-0.59

± 3.42

-4.38

± 7.05

-8.45

± 10.06

8.12

± 10.78

2.65

± 11.35

NR: Normal range, Δ: Difference to norm, *: Deviation from the norm

HHS Vulnerability Disclosure